ISSN: 1837-9664Journal of Cancer
Global reach, higher impact
J Cancer 2022; 13(10):3137. doi:10.7150/jca.76980 This issue Cite
Erratum
Metformin in combination with JS-K inhibits growth of renal cell carcinoma cells via reactive oxygen species activation and inducing DNA breaks: Erratum
Yuwan Zhao*, Qiuming Luo*, Jierong Mo*, Jianwei Li, Dongcai Ye, Zhixian Ao, Lixin Chen, Jianjun Liu 
Laboratory of Urology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong 524001, China
*Contributed equally
Citation:
Zhao Y, Luo Q, Mo J, Li J, Ye D, Ao Z, Chen L, Liu J. Metformin in combination with JS-K inhibits growth of renal cell carcinoma cells via reactive oxygen species activation and inducing DNA breaks: Erratum. J Cancer 2022; 13(10):3137. doi:10.7150/jca.76980. https://www.jcancer.org/v13p3137.htm
Other stylesCorrected-article in J Cancer, Volume 11, 3701
Recently, we conducted an examination of our published article and found errors in Fig 5A.
In Fig 5A, the control group and NAC group's cell morphology picture of A498 were repeated. It was a mistake. When the pictures were combined, the names of the groups were not carefully checked. Also, the cell morphology images of NAC and GSSG groups of ACHN were repeated. We made these mistakes during the assembly of the images. Below is the corrected figure 5.
Figure 5
Corrected figure.
Author contact
Corresponding author: Dr Jianjun Liu, Laboratory of Urology, Affiliated Hospital of Guangdong Medical University, 57 Renmin Street South, Zhanjiang, Guangdong 524001, China. Email: jianjunliulabcom
Published 2022-8-19
Citation styles
APA
Zhao, Y., Luo, Q., Mo, J., Li, J., Ye, D., Ao, Z., Chen, L., Liu, J. (2022). Metformin in combination with JS-K inhibits growth of renal cell carcinoma cells via reactive oxygen species activation and inducing DNA breaks: Erratum. Journal of Cancer, 13(10), 3137. https://doi.org/10.7150/jca.76980.
ACS
Zhao, Y.; Luo, Q.; Mo, J.; Li, J.; Ye, D.; Ao, Z.; Chen, L.; Liu, J. Metformin in combination with JS-K inhibits growth of renal cell carcinoma cells via reactive oxygen species activation and inducing DNA breaks: Erratum. J. Cancer 2022, 13 (10), 3137. DOI: 10.7150/jca.76980.
NLM
Zhao Y, Luo Q, Mo J, Li J, Ye D, Ao Z, Chen L, Liu J. Metformin in combination with JS-K inhibits growth of renal cell carcinoma cells via reactive oxygen species activation and inducing DNA breaks: Erratum. J Cancer 2022; 13(10):3137. doi:10.7150/jca.76980. https://www.jcancer.org/v13p3137.htm
CSE
Zhao Y, Luo Q, Mo J, Li J, Ye D, Ao Z, Chen L, Liu J. 2022. Metformin in combination with JS-K inhibits growth of renal cell carcinoma cells via reactive oxygen species activation and inducing DNA breaks: Erratum. J Cancer. 13(10):3137.
This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.